Tumor-Associated Macrophages: A Potential Target for Cancer Therapy

被引:55
|
作者
Tan, Yifan [1 ]
Wang, Min [2 ]
Zhang, Yang [3 ]
Ge, Shengyang [1 ]
Zhong, Fan [3 ]
Xia, Guowei [1 ]
Sun, Chuanyu [1 ]
机构
[1] Fudan Univ, Huashan Hosp, Dept Urol, Shanghai, Peoples R China
[2] Wuhan Univ, Dept Urol, Renmin Hosp, Wuhan, Peoples R China
[3] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Dept Syst Biol Med, Shanghai, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
tumor-associated macrophages; tumor microenvironment; cancer immunotherapy; macrophages; cancer; CHEMOKINE LIGAND 2; HUMAN MONOCLONAL-ANTIBODY; CARLUMAB CNTO 888; STEM-CELLS; OPEN-LABEL; T-CELLS; INFLAMMATION; ANGIOGENESIS; RESISTANCE; EXPRESSION;
D O I
10.3389/fonc.2021.693517
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Macrophages, an important class of innate immune cells that maintain body homeostasis and ward off foreign pathogens, exhibit a high degree of plasticity and play a supportive role in different tissues and organs. Thus, dysfunction of macrophages may contribute to advancement of several diseases, including cancer. Macrophages within the tumor microenvironment are known as tumor-associated macrophages (TAMs), which typically promote cancer cell initiation and proliferation, accelerate angiogenesis, and tame anti-tumor immunity to promote tumor progression and metastasis. Massive infiltration of TAMs or enrichment of TAM-related markers usually indicates cancer progression and a poor prognosis, and consequently tumor immunotherapies targeting TAMs have gained significant attention. Here, we review the interaction between TAMs and cancer cells, discuss the origin, differentiation and phenotype of TAMs, and highlight the role of TAMs in pro-cancer functions such as tumor initiation and development, invasive metastasis, and immunosuppression. Finally, we review therapies targeting TAMs, which are very promising therapeutic strategies for malignant tumors.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Tumor-associated macrophages: a novel potential target for cancer treatment
    Yue Zhi-qiang
    Liu Yu-ping
    Ruan Jun-shan
    Zhou Liang
    Lu Yin
    [J]. CHINESE MEDICAL JOURNAL, 2012, 125 (18) : 3305 - 3311
  • [2] Tumor-associated macrophages:a novel potential target for cancer treatment
    YUE Zhi-qiang
    LIU Yu-ping
    RUAN Jun-shan
    ZHOU Liang
    LU Yin
    [J]. 中华医学杂志(英文版), 2012, (18) : 3305 - 3311
  • [3] The Association between Tumor-associated Macrophages and Glioblastoma: A Potential Target for Therapy
    Heidari, Arash
    Sharif, Pouya Mahdavi
    Rezaei, Nima
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (46) : 4650 - 4662
  • [4] Tumor-Associated Macrophages as Target for Antitumor Therapy
    Sawa-Wejksza, Katarzyna
    Kandefer-Szerszen, Martyna
    [J]. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2018, 66 (02) : 97 - 111
  • [5] Tumor-Associated Macrophages as Target for Antitumor Therapy
    Katarzyna Sawa-Wejksza
    Martyna Kandefer-Szerszeń
    [J]. Archivum Immunologiae et Therapiae Experimentalis, 2018, 66 : 97 - 111
  • [6] Tumor-associated macrophages: Potential target of natural compounds for management of breast cancer
    Malla, RamaRao
    Padmaraju, Vasudevaraju
    Kundrapu, Durga Bhavani
    [J]. LIFE SCIENCES, 2022, 301
  • [7] The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target
    Gambardella, V
    Castillo, J.
    Tarazona, N.
    Gimeno-Valiente, F.
    Martinez-Ciarpaglini, C.
    Cabeza-Segura, M.
    Rosello, S.
    Roda, D.
    Huerta, M.
    Cervantes, A.
    Fleitas, T.
    [J]. CANCER TREATMENT REVIEWS, 2020, 86
  • [8] Tumor-associated macrophages as targets for cancer therapy
    Wahl, LM
    Kleinman, HK
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (21) : 1583 - 1584
  • [9] Targeting Tumor-Associated Macrophages for Cancer Therapy
    Yumul, Roma
    Richter, Maximilian
    Giovani, Michelle
    Kasahara, Noriyuki
    Lieber, Andre
    [J]. MOLECULAR THERAPY, 2014, 22 : S256 - S256
  • [10] Tumor-associated macrophages as a potential therapeutic target in thyroid cancers
    Zhu, Liya
    Li, Xiu Juan
    Gangadaran, Prakash
    Jing, Xiuli
    Ahn, Byeong-Cheol
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (12) : 3895 - 3917